Log in to save to my catalogue

Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma

Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8774012

Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

The association between radiological response and overall survival (OS) was retrospectively evaluated in patients treated with lenvatinib as a first-line systemic treatment for unresectable hepatocellular carcinoma. A total of 182 patients with Child–Pugh class A liver function and an Eastern Cooperative Oncology Group performance status of zero or...

Alternative Titles

Full title

Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8774012

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8774012

Other Identifiers

ISSN

2072-6694

E-ISSN

2072-6694

DOI

10.3390/cancers14020320

How to access this item